Skip to main navigation Skip to search Skip to main content

Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancer

  • D. W. Van Toorn
  • , J. W.R. Nortier
  • , M. Rubach
  • , C. A.M. De Swart
  • , J. C. Huldij
  • , H. Van Tinteren
  • , J. B. Vermorken

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science